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Prostaglandin synthesis inhibition stimulates lithium
reabsorption in Henle's loop in rats
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and HEIN A. KOOMANS
Department of Nephrology and Hypertension, University Hospital, Utrecht, The Netherlands
Prostaglandin synthesis inhibition stimulates lithium reabsorption in
Renle's loop in rats. The effect of prostaglandin (P0) synthesis inhibi-
tion on tubular lithium (Li) handling in the rat was studied by mi-
cropuncture at the late proximal (LPT) and early distal (EDT) tubules.
Animals received no treatment (N = 7), meclofenamate (MECLO; 5
mg/kg i.p. and 5 mg/kg i.v.; N = 7) or indomethacin (INDO, 1 mg/kg
i.v.; N = 6). Whole kidney fractional Li excretion fell from 26.2 1.5%
in control rats to 12.8 1.3% and 14.6 1.3% in MECLO and INDO
treated rats. Fractional delivery of Li to the LPT was not affected by PG
synthesis inhibition. All of the rise in tubular Li reabsorption took place
between the LPT and EDT; at the EDT fractional Li delivery fell from
32.3 2.0% in the control group to 19.1 1.6% and 20.0 1.4% in the
rats given MECLO or INDO. Water reabsorption between the LPT and
EDT also increased. The tubular fluid/plasma Li concentration ratio
([T/P]Li) at the LPT was —1.15 in all groups of rats. At the EDT, this
ratio was —-1.06 in control rats, but only ——0.82 (P < 0.01) in rats
subjected to PG synthesis inhibition. The finding that the [T/P]Li fell
from values exceeding unity at the LPT to values below unity at the
EDT during PG synthesis inhibition indicates that reabsorption of Li
between these sites was stimulated to a greater extent than that of
water. This dissociation strongly suggests that at least part of the
increased Li reabsorption between the LPT and EDT took place in the
water-impermeable thick ascending limb. We conclude: (1) Li reabsorp-
tion lags behind that of water in the proximal convoluted tubules; (2) Li
reabsorption between the LPT and EDT is stimulated during PG
synthesis inhibition, at least in part in the thick ascending limb of
Henle's loop; (3) the fall in Li clearance during PG synthesis inhibition
does not reflect stimulated reabsorption in the proximal convoluted
tubules in the rat.
The lithium (Li) clearance is postulated to be a non-invasive,
quantitative measure of sodium (Na) and water delivery from
the proximal tubules of the kidney [1]. The assumptions on
which this postulate is based include proportionality of water
and Li reabsorption along the entire proximal tubule and
absence of Li reabsorption in more distal segments of the
nephron [1].
The prostaglandin (PG) synthesis inhibitor indomethacin has
been shown to reduce the renal clearance of Li in humans [2, 3]
and rats [4, 5]. This has also been shown for another PG
synthesis inhibitor, meclofenamate, in the rat [6]. Micropunc-
ture studies in rats failed to detect any effect of PG synthesis
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inhibitors on volume reabsorption in the proximal convoluted
tubules, but showed that these agents stimulate chloride reab-
sorption between the late proximal convoluted tubule and the
early distal tubule, presumably in Henle's loop [7, 8]. Micro-
perfusion studies have identified both the thick ascending limb
of Henle's loop [9] and the cortical collecting duct [10] as sites
where PG's may interfere with Na reabsorption.
The above-mentioned observations suggest that PG synthesis
inhibitors stimulate Li reabsorption downstream from the prox-
imal tubules. This would be at variance with one of the
assumptions on which the Li clearance concept is based [1].
The present micropuncture study was designed to identify the
site(s) of enhanced tubular Li reabsorption during PG synthesis
inhibition induced by meclofenamate and indomethacin in the
rat.
Methods
Micropuncture studies were performed on male Sprague-
Dawley rats maintained on a diet containing 300 mmol Na/kg
dry food. The animals had free access to tap water.
Micropuncture protocol
Anesthesia was induced by intraperitoneal injection of mactin
(Byk-Gulden, Germany, 110 mg/kg body wt). The rats were
then placed on a heated animal table, and rectal temperature
was maintained at 36 to 37°C. After tracheostomy, two PE-50
catheters were introduced into the left jugular vein for electro-
lyte and drug infusions. A PE-50 catheter was introduced into
the left femoral artery for blood sampling and continuous blood
pressure monitoring (transducer: Statham P23Db, recorder:
Minimon 7132A, Kontron Instruments).
The bladder was exposed through a midline abdominal inci-
sion and catheterized with a flanged PE-50 catheter. A tapered
PE-50 catheter was placed into the right ureter. Next, the left
kidney was exposed through a lateral extension of the midline
incision. The kidney was placed on a metal holder and sur-
rounded by cottonwool. Agar (2%) was used to form a well
around the kidney to contain warmed mineral oil. The kidney
surface was illuminated using a fiber optic light source. After
introduction of the jugular vein catheters, a continuous infusion
of 17% inulin (polyfructosan, Inutest') and 17 mr'vt L1CI in 0.9%
NaC1 was started at 0.36 ml/100 g body wt/hr. During the first 30
minutes, the infusion solution also contained 5% bovine serum
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albumin. An equilibration period of one hour was observed to
allow recovery from surgery.
Animals in the meclofenamate group (N = 7) were given 5
mg/kg body weight of the drug i.p. 15 minutes after induction of
anesthesia and 5 mg/kg body weight i.v. in five minutes at the
end of surgery. Intraperitoneal administration of meclofena-
mate directly after administration of mactin was avoided,
because mixing of these agents in vitro caused precipitates.
Animals in the indomethacin group (N = 6) were given 1 mg/kg
body weight i.v. at the end of surgery. Pilot studies showed that
these doses caused a sustained reduction in PGE2 excretion to
-10% of control values. Fifty milligrams of either drug (pur-
chased from Sigma Chemicals, St. Louis, Missouri, USA) was
dissolved in 0.5 ml 0.5 M Na2CO3, 2 ml of distilled water and 2
ml of 0.05 M HCI. The solution was diluted to a final volume of
20 ml using 0.15 M NaCl. Fresh solutions were made for each
study. Four of the animals in the control group (N = 7) were
given the vehicle solution by both the i.p. and i.v. route; three
animals only received the vehicle intravenously.
In the equilibration hour that followed surgery, late proximal
and early distal tubule segments were identified by injection of
0.9% NaC1 containing 5% lissamine green into a random prox-
imal tubule segment through a small (outer diameter < 2.5 pm)
sharpened pipette. Selected tubular segments were indicated on
a map of the kidney surface. At the start, midpoint and end of
the micropuncture period, which lasted 90 minutes, a 140 d
arterial blood sample was drawn, In this period, two 45-minute
urine samples were collected in pre-weighed cups. Tubular fluid
collections were made after injecting a column of water-equili-
brated heavy mineral oil stained with 3% Sudan Black, from 2
to 3 late proximal (5 mm) and 2 to 3 early distal (10 mm)
convolutes from different nephrons. Sharpened micro-pipettes
were used with an outer diameter of 8 to 10 pm for distal and 10
to 13 m for proximal tubules. Blood pressure readings were
obtained at one minute intervals during collections, allowing
calculation of an average blood pressure for each collection.
Analytical techniques
Urine and plasma concentrations of Na and K were measured
by flame photometry (Instrumentation Laboratory, IL 543).
Urine Li concentrations were measured by atomic absorption
spectrophotometry (Perkin-Elmer 3030). Inulin concentrations
in urine and plasma were determined photometrically with
indoleacetic acid after hydrolyzation to fructose [lii. The PGE2
concentration in urine was measured by radioimmunoassay
(New England Nuclear, Dupont Biomedical Products).
The volume of tubular fluid samples was determined by
measuring the diameter of the sample under oil. Inulin concen-
trations in tubular fluid were measured according to Vurek and
Pegram [121 with modifications described elsewhere [13]. In
brief, to prevent moist absorption, capillary cuvettes containing
8 nI of tubular fluid in 2 d of 10 mg/mI dimedone in 85%
phosphoric acid were stored in a closed container with silica gel
until pipetting of all samples was completed. Fluorophore
formation was accomplished by mixing and heating the cuvettes
for 10 minutes in a microwave oven. Lithium concentrations in
tubular fluid and deproteinized plasma were determined by
flameless atomic absorption spectrophotometry. Samples of 10
nl were transferred to a piece of tantalum foil inside a graphite
microboat. This microboat was then inserted into a rectangular
Table 1. Body weight, blood pressure, blood composition and PGE2
excretion in control rats and meclofenamate and indomethacin
treated rats
Control(N=7) Meclofenamate(N=7) Indomethacin(N=6)
Bodywtg 272±22 236±13 277±17
MAPmmHg 110±2 99±2° 104±2
{Na] mmol/liter 147 1 148 2 150 2
[K] mmol/liter
[Li] mmol/liier
PGE2-excr. fmol/min
4.67 0.15
0.19 0.01
66 18
5.33 0.12°
0.22 0.018 2°
4.95 0.08
0.22 0.015 2
Data are mean SEM. Abbreviations are: MAP, mean arterial
pressure; Na, sodium; K, potassium; Li, lithium; p, plasma; POE2,
prostaglandin E2.a p < 0.01, meclofenamate or indomethacin vs. control
cuvette of a Thermo Jarrell Ash SH 12 atomic absorption
spectrophotometer, and the sample was atomized at 2300°C.
Both for tubular fluid samples and deproteinized plasma, the
within-day and between-day variation coefficients were 5% and
4%, respectively (at a concentration of 0.25 mmol/liter). The
mean recovery of Li standards added to plasma was 99 4%.
Sodium concentrations in tubular fluid were determined with
the same instrument, by transferring a sample of 0.15 nl to the
microboat (without the tantalum foil) followed by atomization
at 1900°C.
Calculations
Renal clearances and fractional excretions were calculated
using standard formulae. Glomerular filtration was measured as
the clearance of inulin. Single nephron GFR was measured as
tubular flow rate x [T/PJJ. Fractional delivery of water was
calculated as (l/[T/P]1) x 100%. Fractional delivery of Na or Li
("x") to a tubule segment was calculated as ([T/P]/fT/P]5) x
100%.
Statistical analysis
Results are expressed as mean SE. Clearance data are from
the left, experimental kidney. Comparison between groups was
made using a one-way analysis of variance. If a variance ratio
(F) reached statistical significance (P < 0.05), the differences
between the means were analyzed by the least significant
difference test [14], using the interaction mean square error to
calculate the least significant difference.
Results
Whole animal data and urinary prostaglandin E2 excretion
Both PG synthesis inhibitors reduced PGE2 excretion to
—10% of the values observed in untreated rats (Table 1). Blood
pressure was significantly lower in the meclofenamate-treated
rats. Both PG synthesis inhibitors increased the plasma potas-
sium concentration, although the increment reached statistical
significance only in the meclofenamate-treated group. Plasma
Li concentrations tended to be higher during PG synthesis
inhibition.
Whole kidney clearance data
Clearance data from the experimental (left) kidney and the
contralateral (right) kidney were not different (data not shown).
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Table 2. Effects of meclofenamate and indomethacin on clearance
data
Control
(N=7)
Meclofenamate
(N=7)
Indomethacin(N=6)
GFR mi/mm
FENa %
FEK %
FELL %
rine .d/min
1.47 0.17
0.85 0.07
21.6 1.2
26.2 1.5
6.8 0.9
1.11 0.06
0.21 003b
14.7 11b
12.8 1.3"
3.5 0.2a
1.48 0.15
0.25 0.04"
17.0 0.9k
14.6 1.3"
4.8 o.6
Data are mean SEM. Abbreviations are: GFR, glomerular filtration
rate; FE, fractional excretion; Na, sodium; K, potassium; Li, lithium;
Vurine, urine flow rate.
a p < 0.05, bp < 0.01, meclofenamate or indomethacin vs. control;
data are from the left kidney).
Whole kidney GFR tended to fall during meclofenamate treat-
ment, but remained unaltered during indomethacin infusion
(Table 2). Treatment with meclofenamate and indomethacin
reduced fractional Li excretion (FELl) by roughly 50%. Both
drugs also reduced Na, potassium and water excretion.
Micropuncture data
The single nephron GFR (SNGFR) measured at the late
proximal convoluted tubules was reduced during PG synthesis
inhibition, although the difference with control values reached
statistical significance only after indomethacin treatment. When
measured at the early distal tubules, SNGFR was reduced after
administration of both PG synthesis inhibitors. Similarly, the
tubular fluid flow rate at the late proximal tubules was signifi-
cantly reduced only after indomethacin administration, whereas
early distal tubular fluid flow rate fell in both groups subjected
to PG synthesis inhibition (Table 3).
Table 3 also shows that the fractional delivery of Li, Na and
water to the late proximal convoluted tubules was not affected
by PG synthesis inhibition. As shown in Figure 1, the [TIP]Li
ratio at the late proximal tubules was 1.14 0.02 in untreated
rats, a value significantly greater than unity (P < 0.01). Similar
values were measured in rats during PG synthesis inhibition.
In contrast, the fractional deliveries of Li, Na and water to
the early distal tubules were all significantly reduced during PG
synthesis inhibition (Table 3). In untreated rats, Li reabsorption
between the late proximal and early distal puncture sites
amounted to 31.5 2.2% of the filtered load. Reabsorption of
water (25.6 2.0% of the filtered load) lagged somewhat
behind. Consequently, the [T/P}Li ratio at the early distal
tubules (1.06 0.05, not different from unity) was slightly lower
than at the late proximal convoluted tubules (Fig. 1). During PG
synthesis inhibition, Li reabsorption between the late proximal
and early distal puncture sites increased to 41.7 2.3%
(meclofenamate) and 44.7 4.5% (indomethacin) of the filtered
load. Reabsorption of water between the two puncture sites
increased to a lesser extent (to 30.4 2.4% and 30.1 3.8% of
the filtered load, respectively). This is clearly reflected by the
reduction in [TIP]Li ratio at the early distal tubules, which fell
to 0.81 0.04 (meclofenamate) and 0.84 0.08 (indomethacin)
during PG synthesis inhibition (Fig. 1); both values were
significantly less than unity.
The fall in fractional Li delivery to the early distal tubules
during PG synthesis inhibition was accompanied by a reduction
in Na delivery. However, the reduction in delivery of Na to the
early distal tubules (to —70% of control values) appeared to be
somewhat less pronounced than that in Li delivery (to —60% of
control values). A different effect of PG synthesis inhibition on
Na and Li reabsorption in the loop segment is also suggested by
the early distal [TIP] ratios, which fell significantly for Li but
not for Na (Table 3). When reabsorption was expressed as a
fraction of the load delivered to the ioop segment, reabsorption
of Li was indeed stimulated to a greater extent (from 49 2%
to 68 2%) than that of Na (from 81 2% to 87 1%) during
PG synthesis inhibition (Fig. 2).
In untreated rats, fractional Li delivery to the early distal
tubules (32.3 2.0%) exceeded FELl in the urine (26.2 1.5%);
the difference of 6.1 1.7% was statistically significant (P <
0.05). When expressed as a fraction of the filtered load of Li, the
difference remained constant during meclofenamate (6.3
1.3%) and indomethacin (5.4 2.1%) treatment. When the
difference was expressed as a fraction of the load of Li
delivered to the early distal tubules, an increase was observed
from 18 4% in control rats to 32 5% and 25 9% during
meclofenamate and indomethacin treatment, respectively.
However, these differences failed to reach statistical signifi-
cance.
In view of the reduction in blood pressure induced by
meclofenamate and a similar tendency during indomethacin
treatment, we analyzed whether there was a relation between
blood pressure and early distal Li delivery. Figure 3 clearly
indicates that such a relationship was not found in either control
rats or animals subjected to PG synthesis inhibition.
Discussion
In the present study, prostaglandin (PG) synthesis inhibition
markedly stimulated tubular Li reabsorption in the rat, FELl
being reduced by —50%. Micropuncture of superficial nephrons
was used to identify the site of enhanced tubular Li reabsorp-
tion.
Fractional delivery of Li to the late proximal convoluted
tubules was not different in control rats and animals given
meclofenamate or indomethacin; likewise, the delivery of Na
and water was unaffected. This agrees with earlier micropunc-
ture studies demonstrating that PG synthesis inhibitors do not
affect reabsorption in the proximal convoluted tubules of the rat
kidney [7, 8].
In contrast, reabsorption of Li, water and Na between the
end of the proximal convoluted tubules and the early distal
tubules increased markedly during PG synthesis inhibition.
When analyzing the data obtained during PG synthesis inhibi-
tion together, roughly half of the rise in Li reabsorption
between the two collection sites (—13% of the filtered load) was
matched by increased water reabsorption (—7% of the filtered
load). It cannot be excluded that this concerned stimulation of
isotonic water and Li reabsorption in the pars recta, where
PGE2 has a mild inhibiting effect on volume and phosphate
reabsorption [15]. However, it is also conceivable that part or
all of the rise in water reabsorption between the two puncture
sites took place in the thin descending limb of Henle's loop,
since PG synthesis inhibitors have been shown to increase the
cortico-medullary osmotic gradient [7, 16]. In this case, the
matching amount of Li being reabsorbed could either take place
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Table 3. Micropuncture data in control rats and animals treated with meclofenamate and indomethacin
Tubule
Control(N = 7)
Meclofenamate
(N = 7)
Indomethacin(N = 6)
SNGFR LPT
EDT
nl/min
nI/mm
55.2 2.2
43.8 4.3
49.5 5.0
32.4 2.2a
38.5 1.9°"
31.0 3.1°
Vtf LPT
EDT
nI/mm
nI/mm
30.8 1.7
13.6 1.5
25.9 2.8
7.2 0.4"
20.9 1.5k
7.2 0.7"
[T/P]In LPT
EDT
.—
—
1.83 0.11
3.31 0.13
1.98 0.17
4.66 0.48°
1.89 0.07
4.52 0.46a
[T/P]Na LPT
EDT
—
—
0.93 0.01
0.31 0.02
0.94 0.02
0.28 0.02
0.93 0.02
0.28 0.02
FDH2O LPT
EDT
%
%
56.2 2.8
30.6 1.2
53.7 3.1
23.3 1.8°
53.9 1.9
23.8 2.2a
FDL, LPT
EDT
%
%
63.8 3.1
32.3 2.0
60.8 2.9
19.1 1.6
64.7 4.2
20.0 1.4"
FDNa LPT
EDT
%
%
52.3 3.0
9.4 0.6
50.4 3.1
6.4 0.6k
51.6 2.06.8 o.7
Data are presented as mean SaM. Abbreviations are: SNGFR, single nephron glomerular filtration rate; LPT, late proximal tubule; EDT, early
distal tubule; V,f, tubular fluid flow rate; IT/Pun, tubular fluid/plasma inulin concentration ratio; [T/PJNa, tubular fluid/plasma sodium
concentration ratio; FD, fractional delivery; H20, water; Li, lithium.
a p < 0.05, b p < 0.01, Cp <0.001, meclofenamate or indomethacin vs. controld p < 0.05 indomethacin vs. meclofenamate
LPT EDT LPT EDT LPT EDT
Control MECLO NDO
Fig. 1. Tubular fluid lithium plasma concentration ratio [T/PJLi at the
late proximal convoluted tubules (LPT) and early distal tubules (EDT)
in control rats and animals treated with meclofenamate (MECLO) or
indomethacin (JNDO). Data are presented as mean SEM; (**) P <
0.01, meclofenamate and indomethacin vs. control. Fig. 2. Reabsorption of lithium and sodium in Henle's loop expressed
as a fraction of the load delivered to this segment in untreated rats (0,
and animals subjected to prostaglandin (PG) synthesis inhibition (•) b)
meclofenamate and indomethacin. Data are presented as mean SEM
(**) P < 0.01, (***) P < 0.001 PG synthesis inhibition vs. control.
water reabsorption in the intervening segment, strongly sug
gests that this concerned Li transport in the water-impermeabh
thick ascending limb of Henle (TALH). Lithium transport ii
this nephron segment is conceivable: Li can bind to the Na
binding site of the Na-K-2CL co-transporter [17], aithougl
the affinity of this site for Li is reported to be low [18]. The sam
appears to be true for Li binding to the enzyme Na-K
ATPase [19], which could mediate basolateral extrusion of L
from the cells. Hence, quantitatively important transcellular L
transport seems to be unlikely. Voltage-driven reabsorption vi
the cation-selective paracellular pathway, which has a high L
permeability [20], may be a more plausible mechanism [18].
1.3
0.8 0.81 * *
0.84 * *
0.7
**
0
a-0(I)
a)
a.00
C0
C.)
U-
100
90
80
70
60
50
40
30
20
10
0—
Lithium Sodium
in the thin descending limbs (solvent drag) or the thick ascend-
ing limb (TALH). At present, it is not possible to distinguish
between these possibilities.
However, a considerable part of the rise in Li reabsorption
between the late proximal and early distal collection site was
not matched by increased water reabsorption. This is clearly
reflected by the marked reduction in the early distal [T/P]Li
ratio (Fig. 1). Prostaglandin synthesis inhibition did not alter the
relation between water and Li reabsorption, that is, the [T/P]Li
ratio, in the proximal convoluted tubules. If this is also true for
the pars recta of the proximal tubules, then the dissociation in
water and Li transport between the two puncture sites points to
stimulation of Li reabsorption beyond the pars recta. That the
[T/P]Li ratio fell from 1.14 at the late proximal tubules to values
below unity at the early distal tubules (Fig. 1), despite a rise in
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Fig. 3. Values of fractional lithium delivery to the early distal tubule
(FDLI-EDT) in individual tubules and the corresponding values of the
mean arterial blood pressure (MAP) in control rats (•) and animals
subjected to prostaglandin synthesis inhibition with either meclofena-
mate or indomethacin (+).
Studies showing that the cortico-medullary osmotic gradient
increases during PG synthesis inhibition [7, 161 agree with the
notion that this intervention increases solute uptake in the
TALH in the rat. In addition, earlier micropuncture studies
demonstrated increased chloride uptake between the late prox-
imal and early distal collection site during PG synthesis inhibi-
tion, which was also interpreted as evidence of stimulated
reabsorption in the TALH [7, 8]. It should be noted that these
studies, nor the present one, provided evidence that enhanced
reabsorption in the TALH was a direct tubular effect of PG
withdrawal. However, prostaglandins have been shown to
reduce the lumen-positive electrical gradient [21] and inhibit
reabsorption in the isolated, microperfused TALH [91. This
makes it plausible that PG withdrawal could have direct,
opposite effects on reabsorption in this segment.
Sodium reabsorption between the late proximal and early
distal puncture sites increased along with that of Li during PG
synthesis inhibition (Table 3, Fig. 2). However, the effect of PG
synthesis inhibition on Na reabsorption appeared to be less
pronounced: the reduction in fractional delivery to the early
distal tubules was smaller for Na than for Li, and the fall in
[T/P]Na ratio at this site did not reach statistical significance. At
first sight, a stronger effect of interventions on Li transport in
the TALH is unexpected. The affinity of transporters poten-
tially involved in transcellular Li transport in this segment (such
as the Na-K-2Cl cotransporter and the Na-K-ATPase)
appears to be lower for Li than for Na [17, 19], and the
cation-selective paracellular pathway in the TALH is also less
permeable for Li than for Na [201. A greater affinity of tubular
transport mechanisms for Na between the late proximal and
early distal collection sites in untreated rats is also apparent
from Figure 2, which shows that 81% of Na delivered to the
loop segment had been reabsorbed at the early distal tubules, as
opposed to 49% for Li. A tentative explanation for the finding
that Na transport in the loop segment could be stimulated to a
lesser extent than that of Li during PG synthesis inhibition may
be that near maximum reabsorption had already been achieved
under baseline conditions for Na but not for Li.
Meclofenamate caused a small but statistically significant
decrease in blood pressure, and a similar tendency was ob-
served during indomethacin administration. Conceivably, these
changes in blood pressure could have played a role in stimulat-
ing reabsorption between the late proximal and early distal
collection site. However, the data presented in Figure 3 clearly
illustrate that the effect of PG synthesis inhibition on Li delivery
to the early distal tubules was independent of the decrease in
blood pressure. In agreement with this notion, tubular Li
reabsorption has also been shown to increase in studies in
which blood pressure was not affected by PG synthesis inhibi-
tion [51.
rat.
In contrast to previous reports [7, 8], we found that the single
nephron glomerular filtration rate (SNGFR) of superficial neph-
rons measured at the early distal tubules was reduced during PG
synthesis inhibition. The earlier studies were performed during
acute volume expansion, which may have mitigated the effect of
PG synthesis inhibition on the superficial SNGFR. In accor-
dance with the fall in superficial SNGFR, the whole kidney
GFR tended to fall during meclofenamate treatment, but no
change was observed after indomethacin infusion. This might
indicate that the SNGFR of deep nephrons was relatively well
maintained under the conditions of the present study. That a
reduction in superficial SNGFR without change in deep
SNGFR would not be detectable as a reduction in whole kidney
GFR is conceivable: the SNGFR of deep nephrons is consider-
ably higher than that of superficial nephrons [24] and the latter
are greatly outnumbered by deep nephrons.
The current study demonstrated that reabsorption of Li in
Henle's loop can be stimulated substantially by PG synthesis
inhibition in the rat. This clearly identifies a situation in which
a change in Li clearance does not reflect a proportional change
in reabsorption in the proximal tubules. The question, however,
remains whether a substantial amount of Li is also reabsorbed
in Henle's loop under normal conditions [25]. In the control
group, reabsorption of water and Li between the late proximal
and early distal puncture site was very similar (26 2% and 31
2% of the filtered load, respectively). This near proportional
reabsorption suggests, but obviously does not prove, predom-
inant isotonic reabsorption in the pars recta. Inhibitors of
reabsorption in the TALH, such as furosemide, induce large
increments in FELl [26, 27]. However, since these agents may
also inhibit reabsorption in the proximal tubules [28], these
large increments in FELl do not form definite evidence of
equally important pre-existent Li reabsorption in Henle's loop.
In all groups of rats, the IT/FlU at the end of the proximal
50
40
30
w
20
Li-
10
0
+
85 95 105 115 125 In the untreated animals, we found that the fraction of Li
delivered to the superficial early distal tubules exceeded that
excreted in the urine (FELl) by —6% of the filtered load. This
difference can either be caused by nephron heterogeneity (in
which case less Li would be delivered from deep nephrons) or
by Li reabsorption at a site beyond the early distal tubules. In
the rat, the cortical collecting duct has been identified as such a
site, albeit specifically during dietary Na restriction [22, 23].
From the present study, it cannot be determined which of the
above-mentioned options actually caused the difference be-
tween early distal and urinary Li delivery in the control group.
Nevertheless, the finding that the difference did not increase
during PG synthesis inhibition indicates that this intervention
did not stimulate Li reabsorption in the cortical collecting ducts
or specifically increased Li reabsorption in deep nephrons in the
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convoluted tubules was found to be greater than unity (Fig. 1).
Hence, reabsorption of Li appeared to lag behind that of water
in the accessible part of the proximal tubules. These findings are
at odds with the first micropuncture study of tubular Li handling
in rats, which reported a late proximal [T/PJLi ratio of one [29].
However, in agreement with our results, more recent studies
reported values of 1.13 and 1.09 [30, 31]. These findings do not
support proportionality of water and Li transport in the proxi-
mal tubules, one of the main assumptions underlying the
postulate that the Li clearance is a measure of water delivery
from the proximal tubules [1].
In summary, the present study demonstrates that pros-
taglandin synthesis inhibition with meclofenamate and indo-
methacin stimulates tubular Li reabsorption in rats. This in-
creased reabsorption was shown to be localized between the
late proximal and early distal tubules, presumably to a large
extent in the thick ascending limb of Henle's loop. This study
therefore identifies a condition in which a change in Li clear-
ance does not reflect a similar change in reabsorption in the
proximal tubules. In view of the potential for Li reabsorption in
Henle's loop, changes in Li clearance should always be inter-
preted with caution.
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